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Abstract 
Background: The triglyceride glucose (TyG) index has been suggested as a simple surrogate marker of insulin resist-
ance. However, there are limited data regarding the association between the TyG index and arterial stiffness in adults. 
Therefore, we evaluated the relationship between the TyG index and arterial stiffness as measured based on brachial 
ankle pulse wave velocity (baPWV) in Korean adults.
Methods: A total of 3587 subjects were enrolled in this study. Anthropometric and cardiovascular risk factors were 
measured. The TyG index was calculated as ln[fasting triglycerides(mg/dl) × fasting glucose(mg/dl)/2], and the insulin 
resistance index of homeostasis model assessment (HOMA-IR) was estimated. Arterial stiffness was determined by 
measuring baPWV.
Results: The subjects were stratified into four groups based on the TyG index. There were significant differences in 
cardiovascular parameters among the groups; the mean baPWV increased significantly with increasing TyG index. 
According to the logistic regression analysis after adjusting for multiple risk factors, the odds ratio (95% CI) for 
increased baPWV (> 75th percentile) for the highest and lowest quartiles of the TyG index was 2.92 (1.92–4.44) in men 
and 1.84 (1.15–2.96) in women, and the odds ratio for increased baPWV for the highest and lowest quartiles of the 
HOMA-IR was 1.80 (1.17–2.78) in men and 1.46 (1.06–2.47) in women, respectively.
Conclusion: The TyG index is more independently associated with increased arterial stiffness than HOMA-IR in 
Korean adults.
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Background
Cardiovascular disease (CVD) is a leading cause of death 
worldwide [1]. In particular, arterial stiffness as measured 
by brachial–ankle pulse wave velocity (baPWV) has been 
established as an independent predictor of not only car-
diovascular events but also cardiovascular mortality [2].
Insulin resistance (IR) is one of the most important 
risk factors for CVD [3]. IR is associated with obesity, 
hypertension, and dyslipidemia, all of which predispose 
individuals to atherosclerosis and CVD [4]. Indeed, pre-
vious studies have demonstrated an independent associa-
tion between IR and cardiovascular events [5, 6].
Many recent studies have shown that the triglyceride 
glucose (TyG) index is associated with IR, as assessed by 
hyperinsulinemic euglycemic clamp testing and HOMA-
IR. Thus, the TyG index has been proposed as a reliable 
and simple surrogate marker of IR [7–10].
Consistent with these data, there is growing evidence 
to suggest that the TyG index is associated with car-
diovascular disease [11–13]. However, few studies have 
examined the relationship between the TyG index and 
subclinical atherosclerosis [11, 14, 15]. Moreover, to the 
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best of our knowledge, there has to date only been one 
study, which was performed in a small population of 
women, to investigate the relationship between the TyG 
index and arterial stiffness [16]. Therefore, in the present 
study, we investigated the relationship between the TyG 
index and arterial stiffness and compared the data with 
that of HOMA-IR in Korean adults.
Methods
Study population
The study population consisted of 5989 Korean subjects 
who participated in a comprehensive health examination 
as part of a self-referred health checkup program at the 
Gangnam Severance Hospital Health Promotion Center 
from January 2008 to February 2015. The exclusion cri-
teria of this study were: subjects with elevated triglycer-
ide levels (> 400 mg/dl) and subjects with any history of 
malignancy, acute inflammatory disease, infectious dis-
ease, or renal disease. We also excluded subjects with a 
history of hypertension, angina, myocardial infarction, 
cerebrovascular accident, or an ankle–brachial index 
(ABI) < 0.90. Subjects taking statins or triglyceride-low-
ering medications (fenofibrate or omega-3) were also 
excluded. In addition, we excluded men and women with 
a history of alcohol consumption in excess of 30 and 20 g/
day, respectively. After applying the exclusion criteria, 
a total of 3587 subjects were enrolled in our final analy-
sis. The study protocol was approved by the Institutional 
Review Board of Yonsei University College of Medicine.
Clinical characteristics
We measured the height and weight of each study par-
ticipant and calculated the body mass index (BMI, kg/
m2). Lifestyle information, personal medical history of 
acute and chronic illnesses, and medication history were 
collected using a standard questionnaire. Systolic and 
diastolic blood pressures (SBP, DBP) were measured by 
experienced technicians using an automated blood pres-
sure (BP) monitor (HEM-7080IC; Omron Healthcare, 
Lake Forest, IL, USA) after a 5-min rest period with the 
patient’s arm placed at heart level. The diagnosis of dia-
betes mellitus was based on a previous history of dia-
betes or the ADA’s diagnostic guidelines. Hypertension 
was defined as systolic and/or diastolic blood pressures 
> 140/90  mmHg or the current use of an antihyperten-
sive medication. Current smokers were defined as having 
smoked cigarettes regularly over the previous 6 months.
Biochemical parameters
Blood samples were obtained from all subjects after 8 h 
of fasting. Samples were immediately centrifuged, and 
the serum samples were stored at − 70  °C until analy-
sis. The fasting plasma glucose (FPG), total cholesterol 
(TC), high-density lipoprotein cholesterol (HDL-C), and 
triglycerides (TG) were determined using enzymatic 
methods with a Hitachi 7600–120 automated chemistry 
analyzer (Hitachi, Tokyo, Japan). Low-density lipopro-
tein cholesterol (LDL-C) was calculated according to 
the Friedewald formula. The TyG index was calculated 
as ln[fasting triglycerides (mg/dl) × fasting glucose (mg/
dl)/2] [7]. The fasting serum insulin level was determined 
by chemiluminescence with an RIA kit (Daiichi, Japan). 
Insulin resistance was estimated using the homeosta-
sis model assessment of insulin resistance (HOMA-IR) 
index calculated as fasting insulin (μU/mL) × fasting 
plasma glucose (mmol/L)/22.5.
Pulse wave velocity
Arterial stiffness was measured using an automatic ple-
thysmographic instrument (VP-1000; Colin, Komaki, 
Japan) as previously described [17]. Briefly, electrodes 
were placed on both wrists, and cuffs were wrapped 
around both the upper arms and ankles. After simulta-
neous measurement of blood pressure and waveforms in 
all four limbs, the time interval between the brachial and 
ankle waveforms (ΔTba) was determined. The distance 
between the brachium and the ankle (La − Lb) was esti-
mated automatically according to the subject’s height. 
After these data were collected, baPWV was calculated 
using the following equation: baPWV = (La − Lb)/ΔTba 
(in cm/s). Both baPWV values were measured after 
allowing the patient to rest in a supine position for at 
least 5 min. The mean of the right and left baPWV was 
used as a marker of arterial stiffness.
Statistical analysis
Continuous variables with normal distributions were 
expressed as the mean ± standard deviation (SD), 
whereas continuous variables with skewed distributions 
were expressed as the medians with interquartile ranges 
and were log transformed for analysis. Intergroup com-
parisons were performed using ANOVA. Chi square tests 
were used to compare categorical variables with percent-
ages. Age-adjusted baPWV means and standard errors 
were calculated using analysis of covariance (ANCOVA) 
according to TyG quartiles. The relationships between 
the baPWV and various clinical parameters were exam-
ined using Pearson’s correlation. The odds ratios (OR) 
and corresponding 95% confidence intervals (CI) for high 
PWVs were estimated by multivariate logistic regres-
sion analysis after adjusting for confounding variables 
across TyG index and HOMA-IR quartiles. Covariates 
in the multivariable model, which were chosen for their 
clinical importance, as well as statistical significance, 
were age, SBP, BMI, LDL-C, HDL-C, diabetes mellitus, 
and menopause in women. Because an absolute cut-off 
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value of normal baPWV was not available, high baPWV 
was arbitrarily defined as a value greater than the cut-off 
level between the third and fourth quartiles (> 75th per-
centile), which was 1437.5 cm/s for men and 1411.5 cm/s 
for women. All statistical analyses were performed using 
SPSS for Windows 23.0 (SPSS Inc., Chicago, IL, USA). 
P values less than 0.05 were considered statistically 
significant.
Results
Baseline characteristics
Table 1 shows the clinical and laboratory characteristics 
of the study population. Subjects were stratified into four 
groups based on their TyG index levels. Significant dif-
ferences in metabolic parameters were observed among 
the groups. SBP, DBP, BMI, FPG, TC, TG, LDL-C, and 
HOMA-IR were all positively associated with the TyG 
index, while HDL-C was negatively associated with the 
TyG index. In addition, smoking status and the preva-
lence of diabetes were positively associated with TyG 
index quartiles.
We found that baPWV was positively associated with 
increasing TyG quartiles. Figure 1 shows the age-adjusted 
mean baPWV according to TyG index quartiles in the 
overall population, where Q1 = 1308.9, Q2 = 1338.4, 
Q3 = 1352.9, and Q4 = 1387.7  cm/s (P < 0.01). For 
men, the age adjusted mean baPWVs of the TyG index 
quartiles were 1344.9, 1358.2, 1360.7 and 1394.3  cm/s 
(P < 0.01), while for women the age-adjusted mean baP-
WVs in the four quartiles were 1291.8, 1318.0, 1337.9 and 
1361.1 cm/s, respectively (P < 0.01).
Correlation between the baPWV and clinical variables
Pearson’s correlation analysis was used to examine the 
relationship between the baPWV and clinical variables. 
The baPWV was significantly correlated with age SBP, 
DBP, BMI, TC, LDL-C, HDL-C, TG/HDL-C, LDL-C/
HDL-C, non HDL-C HOMA-IR, and the TyG index 
(Table 2).
Logistic regression analysis of TyG index, HOMA‑IR 
and high baPWV
The association between the TyG index and high baPWV 
was further explored by categorizing the TyG index levels 
Table 1 Clinical characteristics of the study population according to TyG index
Data are the mean ± SD, number (percentage), or median (interquartile range)
SBP systolic blood pressure, DBP diastolic blood pressure, BMI body mass index, FPG fasting plasma glucose, TC total cholesterol, TG triglyceride, LDL-C low-density 
lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, TyG triglyceride glucose, HOMA-IR homeostasis model assessment of insulin resistance
Q1 (lowest) Q2 Q3 Q4 (highest) P value
N 897 896 898 896
Age (years) 49.91 ± 9.83 52.88 ± 8.99 53.30 ± 8.77 52.03 ± 8.68 < 0.01
Sex (M/F) 286/611 433/463 601/297 741/155 < 0.01
SBP (mmHg) 114.60 ± 12.11 117.75 ± 11.94 120.67 ± 10.96 121.99 ± 10.61 < 0.01
DBP (mmHg) 71.42 ± 8.33 73.68 ± 8.03 75.90 ± 7.18 77.14 ± 7.23 < 0.01
BMI (kg/m2) 21.82 ± 2.65 22.99 ± 3.02 23.89 ± 2.78 25.04 ± 2.69 < 0.01
FPG (mg/dL) 85.49 ± 8.92 92.54 ± 9.97 96.87 ± 12.59 102.45 ± 18.17 < 0.01
TC (mg/dL) 183.15 ± 33.16 192.48 ± 33.16 193.78 ± 34.35 200.77 ± 35.14 < 0.01
TG (mg/dL) 55 (48–62) 79 (72–88) 111 (99–122) 180 (153–226) < 0.01
LDL-C (mg/dL) 109.47 ± 29.61 120.93 ± 30.02 123.14 ± 30.93 123.30 ± 31.76 < 0.01
HDL-C (mg/dL) 58.60 ± 12.95 53.26 ± 12.02 47.59 ± 10.88 42.10 ± 8.62 < 0.01
TyG index 7.73 ± 0.21 8.20 ± 0.11 8.57 ± 0.11 9.16 ± 0.28 < 0.01
HOMA-IR 0.60 (0.41–0.91) 0.87 (0.63–1.28) 1.04 (0.77–1.52) 1.37 (0.88–1.97) < 0.01
Smoking (%) 38 (4.2) 47 (5.2) 80 (8.9) 123 (13.7) < 0.01
Diabetes (%) 1 (0.1) 3 (0.3) 20 (2.2) 72 (8.0) < 0.01
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Fig. 1 Age-adjusted mean baPWV for the overall population, men, 
and women (*, †, ‡P < 0.01 vs Q1)
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into quartiles and using the first quartile as a reference. 
Based on age-adjusted multivariable logistic regression 
analysis, with Q1 set as the reference, the TyG index lev-
els for Q2, Q3, and Q4 were associated with increased 
ORs for high baPWV in all subjects. Both in men and in 
women, this relationship remained statistically significant 
after adjusting for confounding variables. In addition, 
higher HOMA-IR quartiles were significantly associated 
with increasing baPWV, and this relationship remained 
significant even after adjusting for metabolic variables. 
After adjusting for multiple risk factors, the OR (95% CI) 
for increased baPWV in the highest HOMA-IR quar-
tile was 1.80 (1.17–2.78) in men and 1.46 (1.06–2.47) in 
women, whereas the OR of the TyG index in the highest 
quartile was 2.92 (1.92–4.44) in men and 1.84 (1.15–2.96) 
in women, respectively (Table 3).
Discussion
In this study, we identified a significant association 
between the TyG index and baPWV as a marker of arte-
rial stiffness. To the best of our knowledge, this is the 
first study to demonstrate such a relationship between 
the TyG index and arterial stiffness in the general pop-
ulation. Furthermore, our results showed that the TyG 
index is independently and more strongly associated with 
increased arterial stiffness compared to HOMA-IR after 
adjusting for metabolic risk factors.
The TyG index which is a surrogate marker of IR, is 
known to be associated with metabolic parameters and 
CVD [12, 13]. Furthermore, in recent studies, it has been 
proven that the TyG index had some prognostic value 
to predict type 2 diabetes mellitus in normoglycemic 
patients [18] and normal-weight patients [19]. Our study 
showed that most of the metabolic parameters were 
increased or decreased according to TyG index quartiles, 
as expected. These results were consistent with those 
of previous studies [14, 20, 21]. Moreover, we observed 
a significant correlation between the TyG index and 
baPWV.
A few reports have investigated whether the TyG index 
can serve as an independent predictor of subclinical ath-
erosclerosis in both the general population as well as in 
diabetic subjects [11, 14, 15]. However, to date, only one 
Table 2 Correlation between the baPWV and clinical vari-
ables
HOMA-IR data were log-transformed because of their non-normal distribution
PWV pulse wave velocity, SBP systolic blood pressure, DBP diastolic blood 
pressure, BMI body mass index, TC total cholesterol, LDL-C low-density 
lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, TG 
triglyceride, HOMA-IR homeostasis model assessment of insulin resistance, TyG 
triglyceride glucose
r P value
Age 0.507 < 0.01
SBP 0.355 < 0.01
DBP 0.329 < 0.01
BMI 0.062 < 0.01
TC 0.039 < 0.01
LDL-C 0.047 < 0.01
HDL-C − 0.085 < 0.01
TG/HDL-C 0.106 < 0.01
LDL-C/HDL-C 0.079 < 0.01
Non HDL-C 0.071 < 0.01
HOMA-IR 0.188 < 0.01
TyG index 0.189 < 0.01
Table 3 Odds ratios and 95% confidence intervals for high baPWV according to TyG index and HOMA-IR
Model 1: adjusted for age
Model 2: adjusted for age, SBP, BMI, LDL-C, HDL-C, diabetes mellitus, and menopause (women)
OR (95% CI) P for trend
Q1 (lowest) Q2 Q3 Q4 (highest)
TyG index in men
 Model 1 1.00 1.47 (0.99–2.18) 1.55 (1.07–2.26) 2.31 (1.60–3.33) < 0.01
 Model 2 1.00 1.55 (1.02–2.36) 1.81 (1.20–2.71) 2.92 (1.92–4.44) < 0.01
TyG index in women
 Model 1 1.00 1.30 (0.85–1.99) 2.00 (1.33–3.01) 2.35 (1.34–4.64) < 0.01
 Model 2 1.00 1.28 (0.80–2.03) 1.56 (0.97–2.52) 1.84 (1.15–2.96) < 0.01
HOMA-IR in men
 Model 1 1.00 1.24 (0.85–1.83) 1.39 (0.95–2.03) 2.15 (1.48–3.11) < 0.01
 Model 2 1.00 1.19 (0.79–1.78) 1.32 (0.90–1.99) 1.80 (1.17–2.78) < 0.05
HOMA-IR in women
 Model 1 1.00 1.12 (0.87–1.65) 1.38 (0.97–1.85) 2.13 (1.19–3.79) < 0.01
 Model 2 1.00 1.09 (0.85–1.38) 1.31 (0.88–2.01) 1.46 (1.06–2.47) < 0.05
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study has examined the relationship between the TyG 
index and arterial stiffness. Lambrinoudaki et al. showed 
an association between the TyG index and arterial stiff-
ness as measured using the PWV between the common 
carotid artery and common femoral artery [16], but this 
study was small in size and conducted with only post-
menopausal women. However, in the present study, 
which was conducted in a relatively large number of 
healthy adults, we demonstrated that the TyG index was 
independently associated with increased PWV. Com-
pared with HOMA-IR, we found that the TyG index was 
better at predicting increased arterial stiffness, which was 
consistent with previous findings showing that the TyG 
index is more strongly associated with carotid atheroscle-
rosis and the prevalence of CAC than HOMA-IR [14, 15].
Although the mechanism underlying the relationship 
between TyG index and arterial stiffness has not been 
fully elucidated, it may be linked to IR. Indeed, previ-
ous studies have demonstrated that HOMA-IR, which 
reflects insulin resistance, is related to PWV [22–24]. 
Both the TyG index and HOMA-IR are well known rep-
resentative markers of IR, and they are closely related to 
each other. However, our findings showed that the TyG 
index was better associated with arterial stiffness than 
HOMA-IR, which may be explained by the fact that the 
two indices reflect different aspects of IR. Specifically, 
the TyG index reflects IR in the muscle [25, 26], while 
HOMA-IR reflects IR in the liver [6, 27]. Thus, the TyG 
index may better reflect peripheral insulin resistance and 
may be a useful marker of arterial stiffness, including 
carotid and coronary atherosclerosis [14, 15].
Our study had several limitations. First, this was a 
cross-sectional observational study. Thus, a causal rela-
tionship cannot be established based on the results of 
this study. Second, the study population consisted of 
Korean men and women enrolled at a single institution, 
and the proportions of young adults and pre-menopausal 
women were relatively small. Thus, the generalizability 
of the results may be limited. Lastly, we were unable to 
obtain histories of alcohol consumption and smoking in 
a quantitative manner, and we could not adjust for nutri-
tional and exercise habits, which can affect blood triglyc-
eride levels.
Conclusions
We demonstrated a significant association between the 
TyG index and baPWV as a marker of arterial stiffness 
in both sexes. Moreover, the TyG index was found to be 
independently associated with increased arterial stiffness 
to a greater degree than was HOMA-IR. As a marker of 
insulin resistance, the TyG index is a simple to calcu-
late, and it appears to be a useful marker of arterial stiff-
ness and thus reflective of cardiovascular risk. Further 
prospective large-scale studies will be needed to eluci-
date the exact mechanism of the relationship between the 
TyG index and arterial stiffness.
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